Wilmington Savings Fund Society’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Wilmington Savings Fund Society’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.85K	Hold	1,000	–	–	﹤0.01%	1270
2026 Q1	$2.34K	Hold	1,000	–	–	﹤0.01%	1338
2025 Q4	$1.35K	Hold	1,000	–	–	﹤0.01%	1338
2025 Q3	$1.51K	Hold	1,000	–	–	﹤0.01%	1316
2025 Q2	$1.16K	Hold	1,000	–	–	﹤0.01%	1962
2025 Q1	$1.59K	Hold	1,000	–	–	﹤0.01%	1947
2024 Q4	$3.03K	Hold	1,000	–	–	﹤0.01%	1875
2024 Q3	$3.68K	Buy	+1,000	New	+$3.63K	﹤0.01%	1833

Other funds holding ZNTL

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

SCP

Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return

ECM

Evergreen Capital Management Bellevue, Washington $5.7B AUM 32.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CWM

Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return

Wilmington Savings Fund Society's ZNTL Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Zentalis Pharmaceuticals (ZNTL) position steady in Q2 2026 at 1,000 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Wilmington Savings Fund Society first reported a position in ZNTL in Q3 2024 and has held it in 8 quarters since. 15 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

Wilmington Savings Fund Society held 1,000 shares of Zentalis Pharmaceuticals worth $4.85K as of Q2 2026.
Wilmington Savings Fund Society left its Zentalis Pharmaceuticals share count unchanged in Q2 2026.
Zentalis Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1270 holding.
Wilmington Savings Fund Society first reported a position in Zentalis Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
15 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.